Medical Industry Technology Serving Moldova

C&G Evaporator is the leading company in the design and production of vacuum evaporators. Water is life, and far too precious a resource to be wasted. We know this well at C&G Evaporator, which is why we create solutions capable of significantly ...

AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...

VetStem Biopharma has endeavored to improve the lives of animals through regenerative medicine. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, VetStem pioneered the use ...

Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...

Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...

We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...

Founded in 2018 by a team of accomplished scientists with a proven track record in drug discovery and executive leadership in top global biopharmaceutical companies, Regor is a pioneering international biotech company with headquarters in Shanghai, ...

Synchron, an endovascular brain interface company, is a leader in implantable neural interface technology. The clinical-stage company is developing a neuroprosthesis for the treatment of paralysis and the first endovascular implantable ...

Our mission is to provide the world‘s most advanced service platform to unlock chemical matter and help to bring the most innovative medicines to patients. Since the inception of the company, we have successfully pioneered our “structural data ...

Curadigm is an early-stage company focused on shifting the paradigm of therapeutic clearance, bioavailability, and efficacy to improve treatment outcomes for millions of patients. Curadigm was spun-off from Nanobiotix, a late-stage clinical company, ...

numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...

Since 1970, CO2 emissions have increased by about 90%, with emissions from fossil fuel combustion and industrial processes contributing about 78% of the total greenhouse gas emissions increase from 1970 to 2011. This process causes global warming, ...

We are a late-stage biotech company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). Our experienced and dedicated team is committed to making a difference in the lives of patients and their ...

At Cognuse, we believe that technology is the key to revolutionise healthcare. We are a digital health company building IT solutions for healthcare professional and patients. Our focus is to improve guideline adherence to enhance care quality and ...

SWESTEP’s business model is built on, in a responsible manner, develop, manufacture and sell SWESTEP Plants. Each plant is built with the objective of providing a viable and sustainable alternative in order to over time eliminate the current fossil ...

Emerson has boldly transformed to create value for our customers and shareholders. With our newly energized focus on our two core business platforms — Automation Solutions and Commercial & Residential Solutions — we can confront the challenges of an ...

Approximately one-third of the total of 150,000 Dutch epilepsy patients suffer from epileptic seizures for which medication is either ineffective or not entirely effective. Caregivers of epileptic patients want to be able to be on-site quickly in ...

Scientists around the world are working to leap ahead of diseases and to improve our lives with innovation. Aside from brilliant minds and relentless passion, the success of science depends on the quality of the materials used. biotechrabbit is ...

Since 1995 the MOL Katalysatortechnik GmbH has developed economically interesting technologies. Ensuring economical and enviromentally friendly water treatment in cooling circuits using the MOL CLEAN-process. Development of water treatment ...